Antibiotics susceptibility patterns of uropathogenic bacteria: a cross-sectional analytic study at Kanifing General Hospital, The Gambia.
Antibiotics
Antimicrobial resistance
Susceptibility
The Gambia
Urinary Tract Infections
Uropathogenic bacteria
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
received:
05
12
2022
accepted:
04
06
2023
medline:
27
10
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Antimicrobial resistance poses a public health threat for the treatment of community-acquired urinary tract infections. This study determined the susceptibility patterns of uropathogens and associated risk factors among outpatients diagnosed with urinary tract infections at the Kanifing General Hospital in the Gambia. A cross-sectional analytic study was conducted among patients with suspected urinary tract infections at Kanifing General Hospital from March to May 2021. Data on socio-demographic and other risk factors were collected from the study participants using a structured pre-tested questionnaire. Mid-stream urine samples were collected, and bacteria identification and antimicrobial susceptibility testing done using standard microbiological methods. Descriptive and inferential statistical analysis were done to determine factors associated with urinary tract infection at 95% confidence level and a p -value < 0.05. A total of 422 patients were enrolled with 82.5% (348/422) being females. The prevalence of community acquired urinary tract infection was 12.8% (54/422). Escherichia coli was the most prevalent isolate (74.1%, 40/54), followed by Klebsiella spp (8.5%, 10/54). Antimicrobial resistance was highest for Ampicillin (87.0%, 47/54), Trimethoprim/Sulfamethoxazole (77.8%, 42/54) and Tetracycline (75.9%, 41/54). Uropathogens sensitivity was 77.8% (42/54) for Nitrofurantoin and 75.9% (41/54) for Ceftazidime. Being female (aOR 5.90 95% CI = 1.48-23.67), previous history of urinary tract infection (aOR 2.34, 95% CI = 1.06-5.14), use of unprescribed antibiotics (aOR 2.0, 95% CI = 1.05-3.62) and having no formal education (aOR 8.02, 95% CI = 1.04-62.0) were significant factors associated for having uropathogenic bacterial infection. E. coli was the most prevalent uropathogen isolated. Ciprofloxacin, Nitrofurantoin and Ceftazidime were the most sensitive antibiotics. Routine surveillance of susceptibility of uropathogenic bacteria would be helpful to update clinicians on the choice of antibiotics.
Sections du résumé
BACKGROUND
BACKGROUND
Antimicrobial resistance poses a public health threat for the treatment of community-acquired urinary tract infections. This study determined the susceptibility patterns of uropathogens and associated risk factors among outpatients diagnosed with urinary tract infections at the Kanifing General Hospital in the Gambia.
METHODS
METHODS
A cross-sectional analytic study was conducted among patients with suspected urinary tract infections at Kanifing General Hospital from March to May 2021. Data on socio-demographic and other risk factors were collected from the study participants using a structured pre-tested questionnaire. Mid-stream urine samples were collected, and bacteria identification and antimicrobial susceptibility testing done using standard microbiological methods. Descriptive and inferential statistical analysis were done to determine factors associated with urinary tract infection at 95% confidence level and a p -value < 0.05.
RESULTS
RESULTS
A total of 422 patients were enrolled with 82.5% (348/422) being females. The prevalence of community acquired urinary tract infection was 12.8% (54/422). Escherichia coli was the most prevalent isolate (74.1%, 40/54), followed by Klebsiella spp (8.5%, 10/54). Antimicrobial resistance was highest for Ampicillin (87.0%, 47/54), Trimethoprim/Sulfamethoxazole (77.8%, 42/54) and Tetracycline (75.9%, 41/54). Uropathogens sensitivity was 77.8% (42/54) for Nitrofurantoin and 75.9% (41/54) for Ceftazidime. Being female (aOR 5.90 95% CI = 1.48-23.67), previous history of urinary tract infection (aOR 2.34, 95% CI = 1.06-5.14), use of unprescribed antibiotics (aOR 2.0, 95% CI = 1.05-3.62) and having no formal education (aOR 8.02, 95% CI = 1.04-62.0) were significant factors associated for having uropathogenic bacterial infection.
CONCLUSION
CONCLUSIONS
E. coli was the most prevalent uropathogen isolated. Ciprofloxacin, Nitrofurantoin and Ceftazidime were the most sensitive antibiotics. Routine surveillance of susceptibility of uropathogenic bacteria would be helpful to update clinicians on the choice of antibiotics.
Identifiants
pubmed: 37880663
doi: 10.1186/s12879-023-08373-y
pii: 10.1186/s12879-023-08373-y
pmc: PMC10599079
doi:
Substances chimiques
Nitrofurantoin
927AH8112L
Ceftazidime
9M416Z9QNR
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
723Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Open Microbiol J. 2017 Oct 31;11:292-300
pubmed: 29204224
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087935
J Infect Dev Ctries. 2008 Oct 01;2(5):354-8
pubmed: 19745502
Antimicrob Resist Infect Control. 2018 Jul 16;7:82
pubmed: 30026940
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S354-62
pubmed: 26449952
J Infect Chemother. 2018 Apr;24(4):278-283
pubmed: 29292177
Int J Pediatr. 2011;2011:825123
pubmed: 21785610
Afr Health Sci. 2021 Mar;21(1):214-219
pubmed: 34394300
BMC Infect Dis. 2017 Feb 10;17(1):138
pubmed: 28187754
Afr Health Sci. 2016 Dec;16(4):1131-1142
pubmed: 28479906
Asian Pac J Trop Med. 2016 Aug;9(8):771-6
pubmed: 27569886
Medicine (Baltimore). 2017 Sep;96(37):e7834
pubmed: 28906365
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
J Antimicrob Chemother. 2007 Feb;59(2):309-12
pubmed: 17138569
SAGE Open Med. 2021 Mar 16;9:20503121211001162
pubmed: 33796299
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Rev Inst Med Trop Sao Paulo. 2014 Jan-Feb;56(1):55-9
pubmed: 24553609
Ceylon Med J. 2019 Dec 31;64(4):140-145
pubmed: 32120467
Int J Microbiol. 2019 Feb 17;2019:4246780
pubmed: 30906323
Infect Drug Resist. 2019 Jul 11;12:2059-2067
pubmed: 31372013
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Dis Mon. 2003 Feb;49(2):53-70
pubmed: 12601337
BMC Infect Dis. 2019 Nov 8;19(1):950
pubmed: 31703645
BMC Res Notes. 2013 Jul 25;6:292
pubmed: 23885968
PLoS One. 2018 Aug 13;13(8):e0200894
pubmed: 30102698